Join us for the launch of the Center on Inclusive Trade and Development (CITD) “Erasing the And” series.  For too long, issues like development, gender, labor, environment, and health have been viewed as “add-ons” to trade policy.  This series reimagines trade law and policy in a way that puts these issues at the center of the discussion.

Our first “Erasing the And” will focus on trade and access to medicines.  The June 2022 WTO MC12 TRIPS waiver on COVID-19 vaccines has prompted conversation about the measures necessary to improve access to medicines in low- and middle-income countries. The keynote address and panel discussion will explore the impact of this measure, its possible extension to pharmaceuticals and diagnostics, and the broader link between intellectual property, public health, and development.